TinyGemsBreaks Archive - Page 29 of 146

FridayFeb 28, 2025 10:45 am

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) and OS Therapies (NYSE American: OSTX) to Appear on RedChip’s Bloomberg TV Show

Calidi Biotherapeutics (NYSE American: CLDI) and OS Therapies Inc. (NYSE American: OSTX) will be featured on RedChip’s Small Stocks, Big Money™ show, airing on Bloomberg TV this Saturday, March 1, at 7 p.m. ET. Andrew Jackson, CFO of Calidi, will discuss the company’s stem cell-based oncolytic virotherapy platform designed to enhance cancer treatment. Calidi’s lead candidates, CLD-101 and CLD-201, target significant market opportunities estimated between $13 billion and $15 billion in the U.S. OS Therapies CEO Paul Romness will highlight OST-HER2, an immunotherapy targeting HER2-positive osteosarcoma and solid tumors, with potential for accelerated FDA approval. The company also advances a…

ThursdayFeb 27, 2025 10:37 am

TinyGemsBreaks – Consumer Automotive Finance Inc (CAFI) Announces Teleconference with President Brandon Spikes

Consumer Automotive Finance (CAFI), soon to be rebranded as Fifty 1 Labs, Inc., will host a nationwide teleconference on March 12, 2025, via the XSpaces platform. Led by company President and former NFL star Brandon Spikes, the event will provide shareholders with insights into the company's 2025 roadmap, strategic initiatives, and recent efforts to enhance shareholder value, including the retirement of 246 million common shares. The interactive session will feature a Q&A segment, allowing shareholders to engage directly with leadership. To view the full press release, visit https://ibn.fm/bEXty About Fifty 1 Labs, Inc. Consumer Automotive Finance, Inc. (OTCPK: CAFI), soon…

ThursdayFeb 27, 2025 10:20 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Delivers Mullen ONE EV Cargo Van to Orange County, North Carolina

Mullen Automotive (NASDAQ: MULN) announced the purchase and delivery of its Mullen ONE Class 1 EV cargo van to Orange County, North Carolina, for deployment by the county’s Solid Waste Management Department. The order, fulfilled by National Auto Fleet Group, supports Orange County’s Climate Action Plan to transition its fleet to all-electric by 2025. Mullen’s commercial EVs, including the Mullen ONE and Mullen THREE, are available for purchase under Sourcewell’s contract, offering sustainable solutions for government agencies nationwide. To view the full press release, visit https://ibn.fm/7UQGZ About Mullen Automotive Inc. Mullen Automotive is a Southern California-based automotive company building the…

WednesdayFeb 26, 2025 10:30 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Joins Sourcewell Contract for Government EV Purchases

Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, announced that its all-electric commercial vehicles, the Mullen ONE Class 1 EV cargo van and Mullen THREE Class 3 EV cab chassis truck, have been added to National Auto Fleet Group’s (NAFG) Sourcewell contract. This approval allows government agencies and educational institutions to purchase Mullen’s commercial EVs through NAFG without lengthy bidding procedures. Sourcewell, a government agency that streamlines procurement, offers competitively solicited contracts, making fleet acquisition more efficient. NAFG, a California-based dealer, is also an approved California Air Resource Board (“CARB”) HVIP dealer, enabling significant incentives on the Mullen THREE, including…

TuesdayFeb 25, 2025 2:29 pm

TinyGemsBreaks – Consumer Automotive Finance Inc. (CAFI) Initiates ‘Shareholder-Centric Strategy’ to Retire 246 Million Common Shares

Consumer Automotive Finance (OTC: CAFI), a dynamic leader in the sports supplement, fitness equipment, and health and wellness industries, today announced the finalization of an agreement to retire 246 million of its issued and outstanding common shares. “This landmark share retirement exemplifies our management team's resolute focus on creating enduring value for our shareholders,” said Brandon Spikes, chairman of Consumer Automotive Finance. “By reducing our outstanding shares by 246 million, we are not only enhancing the intrinsic value of each remaining share but also signaling our confidence in CAFI's growth trajectory and long-term profitability. This is a deliberate, shareholder-centric strategy…

MondayFeb 24, 2025 1:55 pm

TinyGemsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), Viridi Collaborate on Hybrid Generation Solar Project in Buffalo

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), an independent renewable and clean energy project developer and owner focusing on distributed and community solar projects in Canada and the U.S., was featured in an article published by Buffalo Business First. The piece highlights SolarBank’s collaboration with Viridi on a proposed $7 billion solar project at a former landfill in South Buffalo, which would include 3.06 megawatts of solar generation and 1.2 megawatt-hours of battery storage. While relatively rare, these hybrid generation projects are becoming more common according to Matthew McGregor, senior developer of U.S.…

FridayFeb 21, 2025 8:30 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at European Life Sciences CEO Forum

CNS Pharmaceuticals (NASDAQ: CNSP) announced that CEO John Climaco will present at the 18th Annual European Life Sciences CEO Forum in Zurich on Feb. 26, 2025, at 3:20 p.m. CET / 9:20 a.m. EST; management will also be available for one-on-one meetings with registered investors, and a video webcast of the presentation will be accessible on-demand through the conference presenters portal. To view the full press release, visit https://ibn.fm/XEi92 About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central…

ThursdayFeb 20, 2025 1:01 pm

TinyGemsBreaks – Consumer Automotive Finance Inc. (CAFI) Finalizes Steps for Rebrand to Fifty 1 Labs, Inc. (OTC: FITY)

Consumer Automotive Finance (CAFI) announced it has successfully addressed all final inquiries from FINRA regarding its corporate name and ticker change to Fifty 1 Labs, Inc. (OTC: FITY), expected to be completed within 30 days. Led by former NFL player Brandon Spikes, Fifty 1 Labs focuses on sports nutrition, performance training, and tactical gear, including its Drago Knives and The Quickness brands. The rebrand aligns with the company’s strategic expansion, aiming to enhance visibility and shareholder value in the sports and lifestyle markets. To view the full press release, visit https://ibn.fm/XKCQn About Fifty 1 Labs, Inc. Consumer Automotive Finance, Inc.…

ThursdayFeb 20, 2025 8:30 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights 2025 Outlook at Virtual Investor Conference

CNS Pharmaceuticals (NASDAQ: CNSP) announced its participation in the Virtual Investor Top 5 for ‘25 On-Demand Conference, where CEO John Climaco outlined five key reasons for investors and industry peers to follow the company in 2025. The presentation focused on CNS Pharmaceuticals’ advancements in developing treatments for primary and metastatic brain and central nervous system cancers, emphasizing its strategic initiatives and clinical progress for the year ahead. To view the full press release, visit https://ibn.fm/wXsRi About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic…

TuesdayFeb 18, 2025 12:47 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at 6th Glioblastoma Drug Development Summit

CNS Pharmaceuticals (NASDAQ: CNSP) announced its participation in the 6th Glioblastoma Drug Development Summit, taking place Feb. 18-20, 2025, in Boston. Chief Medical Officer Dr. Sandra Silberman will present on Feb. 20 at 10:45 a.m. ET, discussing novel formulations of anthracyclines and taxanes designed to cross the blood-brain barrier. The company’s lead candidate, Berubicin, has completed patient enrollment in a pivotal study against glioblastoma, with primary analysis data expected in the first half of 2025. CNS Pharmaceuticals is also advancing TPI 287 and plans to engage with the FDA on trial design. Berubicin has received Fast Track and Orphan Drug…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks